The Ordinary Salicylic Acid 2% Solution

Description

Salicylic Acid 2% Solution is a topical solution that contains the active ingredient salicylic acid. The formulation appears as a clear, colorless to pale yellow liquid. Inactive ingredients include propylene glycol, purified water, and ethanol.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The affected area should be covered with a thin layer of the product, applied one to three times daily, depending on the severity of the condition. Care should be taken to ensure even distribution over the entire affected area to maximize therapeutic effect.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

The absence of specific warnings, general precautions, laboratory tests, emergency medical help instructions, and directives for discontinuation of use limits the ability to provide detailed guidance in this section. It is essential for healthcare professionals to remain vigilant and consider the individual patient's clinical context when prescribing or administering the medication.

Healthcare providers are encouraged to monitor patients closely for any adverse effects or unusual symptoms that may arise during treatment. In the absence of specific laboratory tests or monitoring parameters, clinicians should utilize their clinical judgment to determine the appropriate course of action based on the patient's overall health status and response to therapy.

In cases where patients exhibit concerning symptoms or adverse reactions, it is imperative to seek immediate medical assistance and reassess the treatment plan. Regular communication with patients regarding their treatment experience can facilitate early detection of potential issues.

For any uncertainties or specific patient concerns, healthcare professionals should consult relevant clinical guidelines or seek expert advice to ensure safe and effective use of the medication.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this product.

Serious side effects include severe allergic reactions, which may manifest as anaphylaxis.

Common adverse reactions reported include skin irritation, dry skin, and a burning sensation. Less common reactions may involve erythema and peeling skin.

Rare adverse reactions have also been noted, including severe allergic reactions and contact dermatitis.

In the postmarketing experience, hypersensitivity reactions and exacerbation of asthma have been observed in some patients. It is important for healthcare providers to monitor for these reactions and manage them appropriately.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of The Ordinary Salicylic Acid 2% Solution (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use has not been specifically addressed in the available data. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for pediatric patients, including infants, children, and adolescents. Healthcare professionals should exercise caution when considering the use of this medication in the pediatric population due to the lack of specific information.

Geriatric Use

There is no specific information regarding the use of The Ordinary Salicylic Acid 2% Solution in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment outcomes in this population.

Pregnancy

There is currently no information available regarding the use of this product during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this product to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of information related to fetal outcomes and the importance of discussing any potential pregnancy plans with their healthcare provider.

Lactation

There are no specific statements or information regarding nursing mothers or lactation in the provided drug insert for The Ordinary Salicylic Acid 2% Solution. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk are not established. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider general principles of management for suspected cases of drug overdosage.

It is essential to monitor patients closely for any signs or symptoms that may arise following an overdose. Common symptoms may include, but are not limited to, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation.

Activated charcoal may be considered if the patient presents within a suitable timeframe and is alert enough to protect their airway. Additionally, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substances involved.

Continuous monitoring of vital signs and laboratory parameters is recommended to assess the patient's condition and guide further management. Consultation with a poison control center or a medical toxicologist may also be beneficial in complex cases.

Overall, the management of overdosage should be tailored to the individual patient, taking into account their clinical presentation and any underlying health conditions.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young children.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and protected from light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for The Ordinary Salicylic Acid 2% Solution, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)